Clinical Study of Adebrelimab Therapy in the Perioperative Treatment of Gastric Cancer or Gastroesophageal Junction Cancer
A phase 3 trial of Adebrelimab and Oxaliplatin in gastric & gastro-oesophageal junction cancer, run by Shanghai Shengdi Pharmaceutical Co., Ltd, now recruiting.
Overview
Clinical Study of Adebrelimab Therapy in the Perioperative Treatment of Gastric Cancer or Gastroesophageal Junction Cancer is a phase 3 interventional study registered as NCT07522151 by Shanghai Shengdi Pharmaceutical Co., Ltd, with 874 participants planned, started 2026-05-07 and due to reach its primary completion in 2029-12. Interventions recorded: Adebrelimab plus S-1 and oxaliplatin and Adebrelimab blank preparation plus S-1 and oxaliplatin..
Similar pages
not linked directly; found by shared links- TrialStudy of SHR-8068 Combined With Adebrelimab and Platinum-containing Chemotherapy in the Treatment of Advanced Gastric and Esophageal Cancer
Shares Adebrelimab, Oxaliplatin, Jiangsu Hengrui Pharmaceuticals, Gastric & gastro-oesophageal junction cancer and the tag pipeline.
- TrialPh1b/2 Study of the Safety and Efficacy of SHR-A1811 Combinations in Advanced HER2 Expression Gastric Cancer
Shares Adebrelimab, Oxaliplatin, Jiangsu Hengrui Pharmaceuticals, Gastric & gastro-oesophageal junction cancer and the tag pipeline.
- TrialA Trial of Adebrelimab Plus (SHR-A1811/SHR-A1904 With Chemotherapy) or SHR-8068 as Treatment for Gastric/GEJ Cancer
Shares Adebrelimab, Jiangsu Hengrui Pharmaceuticals, Gastric & gastro-oesophageal junction cancer and the tag pipeline.
- TrialA Study of SHR-7367 With Anti-tumor Agents in Patients With Solid Tumors
Shares Adebrelimab, Jiangsu Hengrui Pharmaceuticals and the tag pipeline.
- TrialHRS-4642 Combination With Other Antitumor Therapies in Patients With Solid Tumors
Shares Adebrelimab, Jiangsu Hengrui Pharmaceuticals and the tag pipeline.
- TrialClinical Study on the Treatment of MIBC Patients With SHR-A2102 Injection Combined With Adebrelimab (SHR-1316)
Shares Adebrelimab, Jiangsu Hengrui Pharmaceuticals and the tag pipeline.
- TrialPhase I/II Clinical Study of SHR-1501 Combined With Adbelizumab in Patients With Malignant Tumors
Shares Adebrelimab, Jiangsu Hengrui Pharmaceuticals and the tag pipeline.
- TrialA Trial of SHR-A2102 With Adebrelimab With or Without Other Antitumor Therapy in Advanced or Metastatic Esophageal Cancer
Shares Adebrelimab, Jiangsu Hengrui Pharmaceuticals and the tag pipeline.